Načítá se...
Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
BACKGROUND: Although systemic corticosteroid (SCS) treatment, irrespective of duration or dosage, is associated with adverse outcomes for patients with asthma, the longitudinal effects of this treatment on adverse outcomes, healthcare resource utilization (HCRU), and healthcare costs are unknown. ME...
Uloženo v:
| Vydáno v: | Allergy |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587525/ https://ncbi.nlm.nih.gov/pubmed/29987879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13556 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|